|
Sample ID
|
Total reads
|
Map. effic %
|
MethylC CpG %
|
MethylC CpHpG %
|
MethylC CpHpH %
|
Conv. rate %
|
|---|
|
Control 1
|
9,221,090
|
49
|
39
|
1
|
0
|
100
|
|
Control 2
|
14,000,485
|
28
|
39
|
1
|
1
|
99
|
|
Control 3
|
15,237,052
|
45
|
41
|
1
|
0
|
100
|
|
Control 4
|
16,305,850
|
45
|
48
|
1
|
1
|
99
|
|
Control 5
|
14,146,640
|
50
|
41
|
1
|
1
|
99
|
|
Control 6
|
17,961,183
|
26
|
39
|
0
|
0
|
100
|
|
Control 7
|
21,023,385
|
12
|
42
|
0
|
0
|
100
|
|
Control 8
|
14,287,174
|
45
|
40
|
1
|
1
|
99
|
|
Control 9
|
14,605,142
|
29
|
40
|
0
|
0
|
100
|
|
Control 10
|
19,983,522
|
49
|
50
|
1
|
1
|
99
|
|
Patient 1
|
20,739,258
|
25
|
42
|
0
|
0
|
100
|
|
Patient 2
|
12,830,866
|
51
|
38
|
1
|
1
|
99
|
|
Patient 3
|
16,521,910
|
34
|
43
|
1
|
1
|
99
|
|
Patient 4
|
16,888,563
|
30
|
39
|
1
|
1
|
99
|
|
Patient 5
|
13,589,812
|
51
|
42
|
0
|
0
|
100
|
|
Patient 6
|
14,374,956
|
49
|
43
|
0
|
0
|
100
|
|
Patient 7
|
21,391,108
|
40
|
39
|
1
|
0
|
100
|
|
Patient 8
|
13,587,009
|
37
|
41
|
1
|
1
|
99
|
|
Patient 9
|
13,261,182
|
28
|
61
|
1
|
1
|
99
|
|
Patient 10
|
20,052,690
|
46
|
45
|
1
|
1
|
99
|
- Each sample, as identified by sample ID, has corresponding data showing, total reads, mapping efficiency from bismark, methylated cytosines in three different contexts (CpG, CpHpG and CpHpH). H can be either A, T or C, and the percentage is calculated individually for each context following the equation: % methylation = 100 × methylated Cs/(methylated Cs + unmethylated Cs). The bisulphite conversion rate calculated as the average of the number of Ts (non-methylated Cytosines) divided by coverage for each non-CpG cytosine
